» Articles » PMID: 24079474

The Conventional Management of Male Infertility

Overview
Publisher Wiley
Date 2013 Oct 2
PMID 24079474
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Although the male reproductive function is impaired in about half of infertile couples, the evaluation of male infertility is underrated or neglected even today. In addition to a physical examination and imaging techniques, semen analysis as well as endocrine and genetic analyses should be part of the routine investigation. Few disorders have become subjects of rational treatment of the infertile male, even though, as examples, hypogonadotropic hypogonadism is treatable by gonadotropins and obstructive azoospermia by reconstructive surgery. Early treatment of maldescended testes and sexually transmitted diseases can prevent infertility. Similar pregnancy rates from patients with varicocele following surgery or counseling demonstrate the important role of the physician in the treatment of infertility. In the age of evidence-based medicine, most empirical treatments have been demonstrated to be ineffective. Instead, symptomatic treatment by assisted reproductive techniques has become a central tool to overcome otherwise untreatable male infertility.

Citing Articles

Differentiating between obstructive and non-obstructive azoospermia: A machine learning-based approach.

Haghpanah A, Ayareh N, Akbarzadeh A, Irani D, Hosseini F, Moghadam F BJUI Compass. 2025; 6(2):e493.

PMID: 39963581 PMC: 11832300. DOI: 10.1002/bco2.493.


Empirical Treatments for Male Infertility: A Focus on Lifestyle Modifications and Medicines.

Kaltsas A, Zachariou A, Dimitriadis F, Chrisofos M, Sofikitis N Diseases. 2024; 12(9).

PMID: 39329878 PMC: 11431325. DOI: 10.3390/diseases12090209.


Human Sperm as an In Vitro Model to Assess the Efficacy of Antioxidant Supplements during Sperm Handling: A Narrative Review.

Moretti E, Signorini C, Corsaro R, Giamalidi M, Collodel G Antioxidants (Basel). 2023; 12(5).

PMID: 37237965 PMC: 10215929. DOI: 10.3390/antiox12051098.


Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes.

Mazzilli R, Rucci C, Vaiarelli A, Cimadomo D, Ubaldi F, Foresta C J Endocrinol Invest. 2023; 46(6):1079-1085.

PMID: 36633791 PMC: 10185595. DOI: 10.1007/s40618-022-02000-4.


Evaluation of Azoospermic Patients to Distinguish Obstructive from Non-Obstructive Azoospermia, and Necessity of Diagnostic Testis Biopsy: A Retrospective Study.

Shamohammadi I, Sadighi Gilani M, Kazemeyni S, Hasanzadeh T, Vosough Taqi Dizaj A, Dizavi A Int J Fertil Steril. 2022; 16(3):156-161.

PMID: 36029050 PMC: 9421263. DOI: 10.22074/ijfs.2021.532258.1140.